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Introduction
Klebsiella pneumoniae is one of the most common
nosocomial bloodstream infection (BSI) pathogens in
neonatal intensive care units (NICUs) of developing
countries. Its ability to produce extended-spectrum
beta-lactamases (ESBLs) has caused great concern
worldwide. Early studies reported that high beta-lactam
antibiotic consumption was an independent risk factor
for acquisition of ESBL-producing K. pneumoniae BSI.
Objectives
The objective of this study was to examine the impact of
the reduction of beta-lactam antibiotic consumption on
the incidence of ESBL-producing K. pneumoniae BSI in
an Algerian NICU.
Methods
A comprehensive education campaign was undertaken in
the University Hospital of Blida NICU in the beginning
of 2008 to reduce the beta-lactam antibiotic consumption
in this unit. To measure the impact of this campaign on
the incidence of ESBL-producing K. pneumoniae BSI, a
prospective surveillance of healthcare-associated BSI was
performed from 2008 to 2010 using National Nosocomial
Infection Surveillance (NNIS) System criteria. Antibiotic
consumption was measured by dividing the total days of
beta-lactam antibiotic consumption by the total days of
patients NICU stay.
Results
From 2008 to 2010, a total of 3842 neonates who
remained in the NCIU for more than 48 hours were
included in the study. These patients had total patient-
days of 44,424 and total beta-lactam antibiotic-days of
25,180. Beta-lactam antibiotic consumption decreased
significantly from 71.4 antibiotic-days per 100 patient-
days in 2008 to 41.3 antibiotic-days per 100 patient-days
in 2010 (p < .01). Incidence of ESBL-producing K. pneumo-
niae BSI decreased significantly from 3.6% in 2008 to 0.2%
in 2010 (p < .01), and incidence density decreased signifi-
cantly from 3.2 per 1000 patient-days in 2008 to 0.2 per
1000 patient-days in 2010 (p<.01).
Conclusion
Our findings highlight the need to minimise unnecessary
and inappropriate antimicrobial use (specifically that of
beta-lactam antibiotics) to prevent the acquisition of
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